XTalks

NOVEMBER 7, 2022

These tumor-derived entities are used to derive genomic and proteomic data. Gleich, MD, FACS, Senior Vice President, Medical Department, and Dr. Christopher Huth, PhD, Senior Clinical Trial Manager, Clinical Trial Management. Liquid Biopsy Use in Oncology Clinical Trials.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. What is it Like to Work as a Clinical Scientist? A clinical scientist is often synonymous with: Clinical Research / Clinical Laboratory Scientist.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

Drug Discovery World

OCTOBER 16, 2023

Maina Bhaman, Partner at Sofinnova Partners, says: “The UK is an attractive space for drug discovery companies and a prime environment for investment due to its talent, infrastructure, and genomics research. CellProthera also appointed the Newcastle Centre for Life’s GMP cell therapy centre to produce the ATMP.”

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

APRIL 23, 2020

to 13.30 (BST) / 07:30 to 08:30 (EST).

Genome 40

Genome Genomics Life Science Clinical Trials 40

XTalks

MARCH 25, 2021

Xtalks is proud to announce the launch of the Xtalks Life Science podcast. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Fresh Conversations About Life Science Topics. Sarah is passionate about science communication and journalistic integrity.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

pharmaphorum

NOVEMBER 9, 2020

COVID-19 has sparked a flurry of research and discoveries are being made at an unprecedented rate – but patient participation cannot and should not be left behind in the rush, say leading voices. In April, 73% of clinical trials were stopped, and, as of early October, more than 40% were still on hold. Halting progress.

Clinical Trials 73

Clinical Trials Clinical Trials Clinical Research Research 73

pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. Tailored oncology. Navigating barriers to access.

Genome 104

Genome Genomics Clinical Trials Clinical Trials 104

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97

pharmaphorum

FEBRUARY 10, 2022

These included computational and digital skills, the integration of clinical, industrial, and economic research, and genomic and phenotypic insights. People with the ability to integrate data across the patient pathway, in order to aid both research and treatment development, are, the report says, in particularly high demand.

Life Science 104

Life Science Genome Genomics Research 104

XTalks

NOVEMBER 19, 2021

Cardiac biomarkers can not only serve important roles in the diagnosis, management and prognosis of cardiac diseases, but they can also be significant tools in evaluating treatments in cardiovascular (CV) clinical trials. In CV clinical trials, cardiac biomarkers are most commonly included in efficacy and safety endpoints.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98

Drug Discovery World

DECEMBER 8, 2023

With human clinical trials with AI-designed drugs now ongoing, it’s only a matter of time until the FDA approves its first AI-designed drug. These measures collectively fortify the foundation upon which AI-powered advancements in healthcare and life sciences can confidently build their future.

Gene Therapy 64

Gene Therapy Gene In-Vitro Development 64

The Pharma Data

NOVEMBER 5, 2020

Prior to Lonza, she led External Science and Partnering across the globe for Sanofi R&D. Previously, he was an associate director at Navigant Life Science Consulting. Deep Genomics – Toronto-based Deep Genomics appointed Amanda Kay to the newly-created role of chief business officer.

Genome 40

Genome Genomics Medicine Life Science 40

XTalks

FEBRUARY 27, 2024

Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial. Advances in Rare Disease Clinical Research Orphan Drug Legislation Many countries have implemented orphan drug acts to incentivize the development of treatments for rare diseases. The FDA introduced its Orphan Drug Act in 1983.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Partnerships and Establishing Research Cohorts. Genomic biomarker discovery helps drive the development of innovative new personalized therapies.

Research 98

Research Biobanking Drugs Genome 98

XTalks

DECEMBER 1, 2020

Fortunately, technological advances — such as those pioneered by Menarini Silicon Biosystems — have allowed researchers and healthcare practitioners to decipher these issues, drilling down to single-cell genomic levels to uncover variations that may account for reduced drug efficacy or biochemical resistance. billion in 2019.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

XTalks

FEBRUARY 1, 2021

Montreal, Canada-based Caprion Biosciences announced last week that the clinical research organization (CRO) will rebrand as CellCarta. The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab.

Life Science 98

Life Science Branding Genome Genomics 98

Drug Discovery World

AUGUST 10, 2022

In 1987, researchers developed the chimeric antigen receptor (CAR) as an alternative means to identify cancer cells and direct T cells to attack them. And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today. Training T cells to target tumours.

Manufacturing 98

Manufacturing Gene Genome Genomics 98

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. It also helps to quickly address unplanned changes.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

XTalks

MAY 12, 2022

XTALKS WEBINAR: Using the Pain Catastrophizing Scale in Clinical Research and Practice. The detergent will denature the proteins and result in the release of the viral genomic DNA. Live and On-Demand: Thursday, June 09, 2022, at 11am EDT (4pm BST/UK).

In-Vitro 52

In-Vitro DNA Development Genome 52

pharmaphorum

MARCH 16, 2021

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 113

Doctors Doctor Life Science Clinical Research 113

Pharmaceutical Technology

JUNE 8, 2023

Data in clinical trials For example, huge amounts of data can be mined from electronic health records (EHRs) and other sources to optimise clinical research, from drug identification to treatment plan design. When it is properly utilised, this information can be used to improve patient outcomes.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130